Agreement with Biofargo Inc. and developed mycoplasma culture medium business in the United States
Explaining mycoplasma negation testing technology together with the Chinese Medical Products Adminis
Certification from the market
Upgraded media for M.s, M.o and M.h based on JP and USP
Increased investment in research into mycoplasma-negative test media
Signed a trial sales contract with JieXiao Biological Technology Co,.Ltd,and entrusted them with the sales media for pharmaceutical manufacturers in China
Developing agar media for food manufacturers
The factory was opened and the headquarters began manufacturing agar media. The company then shifted its focus to microbial agar media. The company name was changed to Kusada Life.
Development of agar media of JP and USP
Headquarters moved to Chiba and developed business selling microbial reagents related to pharmaceuti
Established a research institute in Chiba Prefecture and began research on mold.
Upgraded media for M.s, M.o and M.h based on JP and USP
Agreement with Biofargo Inc. and developed mycoplasma culture medium business in the United States
Explaining mycoplasma negation testing technology together with the Chinese Medical Products Adminis
Certification from the market
Increased investment in research into mycoplasma-negative test media
Signed a trial sales contract with JieXiao Biological Technology Co,.Ltd,and entrusted them with the sales media for pharmaceutical manufacturers in China
Developing agar media for food manufacturers
The factory was opened and the headquarters began manufacturing agar media. The company then shifted its focus to microbial agar media. The company name was changed to Kusada Life.
Development of agar media of JP and USP
Headquarters moved to Chiba and developed business selling microbial reagents related to pharmaceuti
Established a research institute in Chiba Prefecture and began research on mold.